Phase III Failures for a Lack of Efficacy can be, in Significant Part, Recovered (Introducing Success Probability Estimation Quantitatively)
The rate of phase III trials failures is approximately 42-45%, and most of them are due to a lack of efficacy. Some of the failures for a lack of efficacy are expected, due to type I errors in phase II and type II errors in phase III. However, the rate of these failures is far from saturating the g...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Milano University Press
2023-07-01
|
| Series: | Epidemiology, Biostatistics and Public Health |
| Subjects: | |
| Online Access: | https://riviste.unimi.it/index.php/ebph/article/view/20638 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|